• 250K

Information updates

EpiPen® supply update

17 May 2018: 

EpiPen® 300mcg adrenaline (epinephrine) autoinjectors continue to be distributed each week via wholesalers to pharmacies. Mylan has recently introduced an EpiPen toll-free hotline 1800 931 625 for inquiries about supply.  If a pharmacy is out of stock the pharmacist should contact their wholesaler/s to obtain stock. If there are any problems they should phone 1800 931 625 (AU) or 0800 168 169 (NZ).

Whilst the use of an expired adrenaline autoinjector is not ideal, research suggests that recently expired devices retain potency. Therefore, if no other adrenaline autoinjector is available, use of a recently expired device to treat anaphylaxis is advised, as stated on the ASCIA website: www.allergy.org.au/health-professionals/anaphylaxis-resources/adrenaline-autoinjector-storage-expiry-and-disposal

Due to safety concerns ASCIA does not recommend doctors, pharmacists and other health professionals in Australia to advise patients or their carers to learn to draw up adrenaline using an adrenaline ampoule, needle and syringe.  Whilst using a recently expired device is not ideal, this is a safer option for patients at risk of anaphylaxis, than using an adrenaline ampoule, needle and syringe. 

In the case of anaphylaxis, patients or their carers should follow instructions on their ASCIA Action Plan www.allergy.org.au/anaphylaxis - Give EpiPen® and call an ambulance by phoning 000 (AU) or 111 (NZ). 

Patients and/or carers who require advice should contact the national patient support organisations, Allergy & Anaphylaxis Australia (phone 1300 728 000 or email This email address is being protected from spambots. You need JavaScript enabled to view it.) or Allergy New Zealand  www.allergy.org.nz


Disclaimer and Privacy

The ASCIA website is intended for use by ASCIA members, other health professionals, the general public and media. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors and Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites.

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.


This website is certified by Health On the Net Foundation. Click to verify.This site complies with the
HONcode standard for
trustworthy health

Verify here.